CME Research Development from 2010 to 2024

CME Stock  USD 212.15  0.99  0.46%   
CME's Research Development is increasing over the years with slightly volatile fluctuation. Overall, Research Development is expected to go to about 229.6 M this year. During the period from 2010 to 2024 CME Research Development annual values regression line had geometric mean of 0.00 and mean square error of 3014 T. View All Fundamentals
 
Research Development  
First Reported
2001-03-31
Previous Quarter
58.5 M
Current Value
59.4 M
Quarterly Volatility
23.3 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check CME financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CME main balance sheet or income statement drivers, such as Depreciation And Amortization of 370.2 M, Interest Expense of 107.7 M or Selling And Marketing Expenses of 171 M, as well as many exotic indicators such as Price To Sales Ratio of 8.04, Dividend Yield of 0.0237 or PTB Ratio of 3.8. CME financial statements analysis is a perfect complement when working with CME Valuation or Volatility modules.
  
This module can also supplement CME's financial leverage analysis and stock options assessment as well as various CME Technical models . Check out the analysis of CME Correlation against competitors.

Latest CME's Research Development Growth Pattern

Below is the plot of the Research Development of CME Group over the last few years. It is CME's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CME's overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Slightly volatile
   Research Development   
       Timeline  

CME Research Development Regression Statistics

Arithmetic Mean81,969,000
Geometric Mean0.00
Coefficient Of Variation127.31
Mean Deviation98,362,800
Median0.00
Standard Deviation104,350,847
Sample Variance10889.1T
Range229.6M
R-Value0.86
Mean Square Error3014T
R-Squared0.74
Significance0.000036
Slope20,112,661
Total Sum of Squares152447.4T

CME Research Development History

2024229.6 M
2023218.7 M
2022188.6 M
2021192.6 M
2020198.5 M
2019201.5 M

About CME Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include CME income statement, its balance sheet, and the statement of cash flows. CME investors use historical funamental indicators, such as CME's Research Development, to determine how well the company is positioned to perform in the future. Although CME investors may use each financial statement separately, they are all related. The changes in CME's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on CME's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on CME Financial Statements. Understanding these patterns can help to make the right decision on long term investment in CME. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Research Development218.7 M229.6 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether CME Group is a strong investment it is important to analyze CME's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CME's future performance. For an informed investment choice regarding CME Stock, refer to the following important reports:
Check out the analysis of CME Correlation against competitors.
You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Complementary Tools for CME Stock analysis

When running CME's price analysis, check to measure CME's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CME is operating at the current time. Most of CME's value examination focuses on studying past and present price action to predict the probability of CME's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CME's price. Additionally, you may evaluate how the addition of CME to your portfolios can decrease your overall portfolio volatility.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Global Correlations
Find global opportunities by holding instruments from different markets
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Is CME's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CME. If investors know CME will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CME listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.03)
Dividend Share
4.45
Earnings Share
8.78
Revenue Per Share
15.638
Quarterly Revenue Growth
0.032
The market value of CME Group is measured differently than its book value, which is the value of CME that is recorded on the company's balance sheet. Investors also form their own opinion of CME's value that differs from its market value or its book value, called intrinsic value, which is CME's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CME's market value can be influenced by many factors that don't directly affect CME's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CME's value and its price as these two are different measures arrived at by different means. Investors typically determine if CME is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CME's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.